AML1 mutation and its coexistence with different transcription factor gene families in de novo acute myeloid leukemia: Redundancy or synergism

Chirayu U. AuewarakulAmporn LeecharendkeatChintana TocharoentanapholOrathai PromsuwichaNarongrit SritanaWanna ThongnoppakhunMahidol UniversityChulabhorn Research Institute2018-08-242018-08-242007-06-01Haematologica. Vol.92, No.6 (2007), 861-862039060782-s2.0-34347211790https://repository.li.mahidol.ac.th/handle/20.500.14594/24864AML1 mutations were identified in 6.3% of AML patients with chromosomal translocations involving CBF, PML-RARα, HOX, or ETS transcription factor (TF) gene families. Rare chromosomal abnormalities, t(16;21) and t(7;11), were also found. This study represents the first series to demonstrate the coexistence of known and novel AML1 mutations with different TF gene mutations. Although the occurrence of two TF gene mutations may appear unnecessary, the possible synergistic mechanism between different TF gene families cannot be excluded and needs to be further explored.Mahidol UniversityMedicineAML1 mutation and its coexistence with different transcription factor gene families in de novo acute myeloid leukemia: Redundancy or synergismArticleSCOPUS10.3324/haematol.10914